Table of Contents Table of Contents
Previous Page  212-213 / 427 Next Page
Information
Show Menu
Previous Page 212-213 / 427 Next Page
Page Background

PDE5 Inhibitors Working Group: Members

Katerina Mastovska, Covance (Chair)

Joe Betz, NIH

Anton Bzhelyansky, USP

Teresa Cain, FDA

Jana Hildreth Blaze Science Industries

Anatoly Chlenov, PerkinElmer

John Edwards, Process NMR

Todd Koch Pfizer

David Kennedy, Phenomenex

James Neal‐Kababick, Flora Research 

Alexander Krynitsky, FDA

Stephen Lock, AB SCIEX

Melissa Phillips, NIST

Steve Royce, Agilent

John Travis NSF International

Elisa Nickum, FDA

Catherine Rimmer, NIST

Brian Schaneberg Starbucks

Lukas Vaclavik, FDA

Jerry Zweigenbaum, Agilent

Olga Shimelis, Supelco

Garrett Zielinski, Covance